期刊文献+

急性缺血性脑卒中MSU与常规救治疗效的对比分析 被引量:8

Comparative analysis of MSU and routine treatment of acute ischemic stroke
原文传递
导出
摘要 目的对比分析应用移动卒中单元(MSU)与常规救治模式对急性缺血性脑卒中(AIS)的治疗效果。方法选取河南大学附属南石医院脑病重症科自2019年10月至2020年1月收治的AIS患者60例,采用随机数字表法将患者分为MSU组(30例)和常规组(30例)。MSU组采用装配了16排移动CT的MSU在卒中发生现场进行神经功能学评估、脑部移动CT扫描诊断及重组组织型纤溶酶原激活物阿替普酶(rt-PA)静脉溶栓治疗;常规组采用常规救治模式,由120现场急救并转运患者至医院,在急诊科进行神经功能学评估、CT脑扫描成像,专家会诊确诊,入住卒中专科进行rt-PA静脉溶栓治疗。对比分析2组患者首次医学接触时间、完成CT脑扫描时间、rt-PA静脉溶栓时间,以及溶栓治疗前后神经功能缺损程度变化和临床疗效。结果MSU组的治疗总有效率高于常规组,差异具有统计学意义(P<0.05)。MSU组首次医疗接触至完成头颅CT检查时间明显少于常规组(平均时间缩短28.72 min),首次医疗接触至静脉溶栓开始时间明显少于常规组(平均时间缩短34.81 min),2组比较差异均具有统计学意义(P<0.05)。MSU组治疗后的美国国立卫生研究院卒中量表评分优于常规组,差异有统计学意义(P<0.05)。结论AIS运用MSU模式进行rt-PA静脉溶栓治疗,可以显著缩短CT脑扫描时间和rt-PA静脉溶栓时间,对改善患者神经功能和提高临床疗效作用显著。 Objective To compare and analyze the effectiveness of mobile stroke unit(MSU)and conventional treatment mode of acute ischemic stroke(AIS).Methods Sixty patients with AIS were selected from Encephalopathy Department of Nanshi Hospital Affiliated to Henan University from October 2019 to January 2020.The patients were randomly divided into MSU group(30 cases)and routine group(30 cases).In the MSU group,MSU equipped with 16-slice mobile CT was used to evaluate the neurological function,brain mobile CT scanning diagnosis and recombinant tissue-type plasminogen activator alteplase(rt-PA)intravenous thrombolysis for AIS.The patients in the routine group under routine treatment mode were initially treatment by first aid on site and transported to the hospital by 120 ambulance.The neurological assessment,brain CT scanning were performed in the Emergency Department.The diagnosis was determined in stroke experts.Then the patients were admitted to the stroke center for rt-PA intravenous thrombolysis.The initial contact time,CT scan time,rt-PA thrombolytic time,and the degree of neurological deficit before and after thrombolytic therapy were compared and analyzed between the two groups.Results The total effective rate of MSU group was higher than that of routine group,the difference were statistically significant(P<0.05).The time from the first medical contact to the completion of head CT examination in MSU group was significantly less than that in routine group(the average time was shortened by 28.72 min),and the time from the first medical contact to the start of intravenous thrombolysis was significantly less than that in routine group(the average time was shortened by 34.81 min).The difference between the two groups was statistically significant(P<0.05).The change of NIHSS score in MSU group was better than that in routine group(P<0.05).Conclusion The use of MSU mode for AIS can significantly shorten the time of brain CT scanning and rt-PA intravenous thrombolysis for the treatment of rt-PA intravenous thrombolysis,which resulted in significant improvement of neurological function and clinical efficacy of AIS patients.
作者 彭兆龙 石军峰 刘斌 袁苗 张洪钿 代秋声 杨磊 徐超 许家林 于强 栗志利 徐如祥 Zhaolong Peng;Junfeng Shi;Bin Liu;Miao Yuan;Hongtian Zhang;Qiusheng Dai;Lei Yang;Chao Xu;Jialin Xu;Qiang Yu;Zhili Li;Ruxiang Xu(Department of Encephalopathy,Nanshi Hospital Affiliated to He’nan University,Nanyang 473000,China;Department of Neurosurgery,Sichuan Academy of Medical Sciences,Sichuan Provincial People’s Hospital,Chengdu 610072,China;BECHOICE(Beijing)Science and Technology Development Ltd.,Beijing 100050,China;Jiangsu Mocoto Medical Technology Co.,Ltd.,Suzhou 215123,China;Langfang Mocoto Medical Technology Co.,Ltd.,Langfang 065000,China)
出处 《中华神经创伤外科电子杂志》 2021年第5期277-280,共4页 Chinese Journal Of Neurotraumatic Surgery:Electronic Edition
基金 全军十二五军事医学重点课题(BWS12J010) 全军十三五军事医学重点课题(20WKS08)。
关键词 急性缺血性脑卒中 移动卒中单元 重组组织型纤溶酶原激活物 静脉溶栓 Acute ischemic stroke Mobile stroke unit Recombinant tissue plasminogen activator Intravenous thrombolysis
  • 相关文献

参考文献8

二级参考文献165

  • 1李慧凤,王鸿雁,庞璨,翁建平.青岛市区中年人群血尿酸水平与心血管危险因素的分析[J].中华医学杂志,2005,85(25):1781-1783. 被引量:19
  • 2毕齐,张茁,张微微,李琴.北京等15个城市脑卒中患者院前时间及影响因素研究[J].中华流行病学杂志,2006,27(11):996-999. 被引量:66
  • 3Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 4Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 5Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 6Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 7Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 8Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 9Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 10Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.

共引文献1119

同被引文献124

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部